Clinical trial
South Asian Arrhythmogenic Cardiomyopathy Registry
NCT04895540 is registered in ClinicalTrials.gov with Sheri Kashmir Institute of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- South Asian Arrhythmogenic Cardiomyopathy Registry
- Lead sponsor
- Sheri Kashmir Institute of Medical Sciences
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 10, 2021
- Completion date
- May 1, 2022
- Enrollment
- 100 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
arrhythmogenic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic right ventricular dysplasia, arrhythmogenic ventricular cardiomyopathy, sudden cardiac death, ventricular tachycardia